Summary Box: Amgen profit rises on lower taxes

Published



EARNINGS BEAT: A big tax break helped biotech giant Amgen post better-than-expected quarterly earnings, despite disappointing drug sales.

SALES MISS: Revenue rose 5 percent to $4.24 billion, but missed analyst expectations of $4.37 billion.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.